Archive: 16/11/2016

Findings support bisphosphonate use in men with osteoporosis

(HealthDay)—Bisphosphonates reduce the risk of vertebral, and possibly nonvertebral, fractures for men with osteoporosis, according to a review and meta-analysis published online Nov. 7 in the Journal of the American Geriatrics ...

Nov 16, 2016

0

0

AHA: Inclisiran twice yearly may effectively control cholesterol

(HealthDay)—A new injectable medication called inclisiran cuts low-density lipoprotein (LDL) cholesterol by half or more, and the effect could last for four to six months, according to research presented at the annual meeting ...

Nov 16, 2016

0

0

Ablative fractional laser beneficial for C-section scars

(HealthDay)—Ablative fractional laser (AFXL) treatment is beneficial for patients with cesarean section (C-section) scars, according to a study published online Nov. 8 in Lasers in Surgery and Medicine.

Nov 16, 2016

0

0

Employment of more nurse assistants is associated with more deaths and lower quality care

Hospitals that employ more nurse assistants relative to the number of professionally qualified nurses have higher mortality rates, lower patient satisfaction, and poorer quality and safety of care, according to a new European ...

Nov 16, 2016

0

2

AHA: secondhand tobacco smoke ups atherosclerosis risk

(HealthDay)—In asymptomatic never smokers, the extent of secondhand tobacco smoke (SHTS) exposure is associated with the presence and extent of atherosclerosis, according to a study published online Nov. 13 in JACC: Cardiovascular ...

Nov 16, 2016

0

0

Alcohol may fuel prostate cancer risk

(HealthDay)—Drinking may raise the risk of prostate cancer, and the more men drink the greater their risk, a new analysis of 27 studies suggests.

Nov 16, 2016

1

4

Early sign-ups for health care law are steady, but no surge

A little more than 1 million people renewed health coverage or signed up for the first time through HealthCare.gov around the start of open enrollment, which coincided with a GOP election sweep likely to scramble President ...

Nov 16, 2016

0

0

Controversial drug approval stirs deep concerns—and hope

In September, the Food and Drug Administration approved Exondys, a controversial treatment for Duchenne muscular dystrophy based on tenuous data from just 12 patients. The cover story in Chemical & Engineering News (C&EN), ...

Nov 16, 2016

UK study to help chronic pain sufferers back to work

Researchers from the University of Warwick's Medical School are leading a novel study to explore ways of helping people with chronic pain back to work.

Nov 16, 2016

Five-year WHO investigation: Treated bed nets still fending off malaria in Africa and India

Bed nets treated with a safe chemical killer still provide significant protection from malaria-carrying mosquitoes, despite the rise in insecticide resistance, according to a major study released today at the annual meeting ...

Nov 16, 2016

0

0

page 4 from 10

«
»